Professional Documents
Culture Documents
Práctico Tiempos Progresivos
Práctico Tiempos Progresivos
Práctico Tiempos Progresivos
There are significant global efforts underway to diagnose, treat and prevent
infections from the virus. Pharmaceutical companies are working globally to
combat COVID-19.
Pharmaceutical companies have deep scientific knowledge gained from decades
of experience with similar viruses. Companies are researching vaccine candidates
and undertaking inventories of research portfolio libraries to identify additional
potential treatments for R&D.
Some have donated compounds with the potential to treat coronavirus for
emergency use and clinical trials, including compounds formerly tested on other
viral pathogens such as Ebola and HIV. Others are exploring ways to use existing
technologies that provide the ability to rapidly upscale production once a potential
vaccine candidate is identified.
AstraZeneca is working with the National Institute of Health Research (NIHR) on a
Phase 3 trial to investigate monoclonal antibodies for the treatment of COVID-19.
Johnson & Johnson. In partnership with the Rega Institute for Medical Research,
University of Leuven (Belgium), J&J is working to identify existing or new
compounds with antiviral activity against COVID-19.
1. ______________________________________
2. ______________________________________
3. ______________________________________
4. ______________________________________
5. ______________________________________
1. The workers were not at that moment trying to cause losses to the
company.
2. Is the new equipment working full time?
3. Some of the brand new computers are not performing as expected.
4. Where were the consultants meeting to take decisions concerning the
safety procedures?
5. Today, software companies are increasingly moving to a software-as-
a-service model.